J45.20

Mild intermittent asthma, uncomplicated

J45.20 is a clinical classification of asthma representing the least severe stage of the disease. It is characterized by episodic airway obstruction and hyperresponsiveness that is reversible, either spontaneously or with treatment. By clinical definition, mild intermittent asthma entails symptoms occurring no more than two days per week, and nighttime awakenings occurring no more than twice per month. Patients typically maintain a normal Forced Expiratory Volume in 1 second (FEV1) of greater than 80% of the predicted value and a normal FEV1/FVC ratio between exacerbations. The 'uncomplicated' designation signifies that the patient is not currently experiencing an acute exacerbation nor is in status asthmaticus. Management focuses on 'as-needed' relief, typically using low-dose inhaled corticosteroids (ICS) with formoterol or short-acting beta-agonists (SABA).

Clinical Symptoms

  • Intermittent wheezing
  • Dry cough, often worsening at night or early morning
  • Shortness of breath (dyspnea) during exertion
  • Chest tightness
  • Quick resolution of symptoms after bronchodilator use
  • Occasional exercise-induced bronchospasm
  • Minimal interference with daily activities
  • Absence of symptoms between episodes

Common Causes

  • Genetic predisposition to atopy
  • Exposure to environmental allergens such as pollen, dust mites, or mold
  • Sensitivity to pet dander
  • Viral upper respiratory infections
  • Airborne irritants including tobacco smoke and air pollution
  • Physical exertion and cold air exposure
  • Occupational exposures to chemical fumes or dusts
  • Strong emotional expressions (laughing or crying) triggering bronchospasm

Documentation & Coding Tips

Distinguish symptom frequency to validate intermittent status.

Example: Patient reports wheezing and shortness of breath occurring only 1 day per week over the last 3 months. No nighttime awakenings reported (0 times per month). Patient uses Albuterol HFA PRN approximately once per week. Normal activity is not limited. FEV1 is 85 percent of predicted value. Diagnosis: Mild intermittent asthma, uncomplicated. Billing Focus: Documentation of symptoms occurring 2 days or fewer per week supports J45.20 specificity. Risk Adjustment: Accurate classification as intermittent prevents over-reporting of severity while capturing the chronic nature of the airway disease.

Billing Focus: Documentation of frequency (2 days or fewer per week) and lack of nighttime awakenings (2 or fewer times per month).

Explicitly state the absence of exacerbation or status asthmaticus.

Example: Assessment: Mild intermittent asthma, currently stable and uncomplicated. There are no signs of acute exacerbation, no increased work of breathing, and the patient is not in status asthmaticus. Current peak flow 450 L/min (baseline 460). Billing Focus: Use of the fifth digit 0 (J45.20) rather than 1 (exacerbation) or 2 (status asthmaticus). Risk Adjustment: Confirms the patient is in a maintenance phase rather than an acute episode which carries different clinical weight.

Billing Focus: Verification of uncomplicated status through negative findings for acute distress.

Document pulmonary function test results to support severity level.

Example: Spirometry performed today shows FEV1 of 3.2L (88 percent predicted) and FEV1/FVC ratio of 0.82. These values are within the normal range, consistent with the diagnosis of mild intermittent asthma. Billing Focus: Clinical evidence (spirometry results) justifies the selection of the mild intermittent code over persistent categories. Risk Adjustment: Objective data supports the clinical diagnosis and defends the severity level during external audits.

Billing Focus: Inclusion of FEV1 and FEV1/FVC ratios to confirm the severity tier.

Identify and document specific triggers for intermittent symptoms.

Example: Mild intermittent asthma, uncomplicated. Symptoms are exclusively triggered by cold air during winter months or heavy exercise (EIB), occurring less than twice weekly. Patient has no history of tobacco use. Billing Focus: Identifying triggers clarifies the clinical profile and reinforces the intermittent nature of the diagnosis. Risk Adjustment: Triggers help define the etiology and potential for future exacerbations within the risk profile.

Billing Focus: Documentation of extrinsic vs. intrinsic triggers to support the asthma classification.

Document rescue inhaler usage frequency.

Example: Patient utilizes ProAir HFA (Albuterol) for symptom relief on average 1 day per week. No recent increase in usage and no refill requests beyond standard intervals. Diagnosis: Mild intermittent asthma, uncomplicated. Billing Focus: SABA usage frequency is a primary clinical indicator for intermittent vs. persistent classification. Risk Adjustment: Medication adherence and usage patterns are key components of the clinical narrative for chronic disease management.

Billing Focus: Frequency of short-acting beta-agonist (SABA) usage per week.

Relevant CPT Codes

Related Diagnoses

Hierarchy